Instructional Courses
Instructional Courses
All Instructional Courses at the Vienna Congress will be Free of Charge.
It is not necessary to register for these courses.

Course Handouts
-
24 September 2018
08:00-10:00 - IC 69
-
Combined cataract and glaucoma surgery: when, what and how
EBO Accredited
Leader: L. Au | Course Level: Intermediate
-
Faculty: K. Merceica S. Lim A. Fea A. Mermoud
COURSE DESCRIPTION: : Cataract and glaucoma are two conditions that co-exist on a frequent basis. Surgeons are sometimes faced with the dilemma of performing either combined or sequential glaucoma and cataract surgery. Both approaches have their benefits and pitfalls. The emergence of minimally invasive glaucoma surgeries (MIGS) in recent years have sparked further interest in combined phaco-glaucoma surgery; there are now many surgical options but it can be difficult to choose the correct surgery for the right patient.
COURSE OBJECTIVES: : Candidate would learn about 1. The need and dilemma of combined cataract and glaucoma surgery 2. The IOP lowering effect of cataract surgery alone 3. The traditional approach of phace-trabeculectomy and phaco deep sclerectomy 4. The multiple options, surgical tips and results of all new MIGS devices including phaco istent/hydrus, ab-internal trabeculotomy, Xen implant and canaloplasty. 5. A comparison of all these surgical options and how to choose the right surgery for the right patient
COURSE SCHEDULE:
1. The need and dilemma of combined cataract and glaucoma surgery - Leon Au (10min) 2. The traditional approach: phaco trabeculectomy / deep sclerectomy - Karl Mercieca (20 min) 3. Phaco-istent: masterclass in abinternal approach - Antonio Fea (20 min) 4. Phaco abinternal trabeculotomy and aqueous outflow - Sheng Lim (20 min) 5. Phaco Xen implant - Andre Mermoud (20 min) 6. Phaco schlemm's canal dilation and scaffolding - Leon Au (15 min) 7. Summary of technology, learning curve and patient selection - Panel discussion (15 min) SINGLE PRODUCT COURSE: No
FINANCIAL DISCLOSURE: , receives consulting fees, retainer, or contract payments from a competing company, , travel has been funded, fully or partially, by a competing company, , travel has been funded, fully or partially, by a company producing, developing or supplying the product or procedure presented, , research is funded, fully or partially, by a competing company, , research is funded, fully or partially, by a company producing, developing or supplying the product or procedure presented